Big Pharma’s traditional playbook for developing medicines required years of data collection and trials before a treatment began its life saving tenure. But drugmakers last year pulled off the onceunthinkable feat of developing a vaccine against Covid-19 in less than a year. Now they’re racing even faster to adapt those shots to protect against the new omicron variant in as little as six weeks. While it may take almost that long to determine if new vaccines are truly needed to deal with the coronavirus’s latest iteration, waiting simply isn’t an option.
This is the scramble that Covid has created. The virus is so destructive that drugmakers have started scientific work to adapt vaccines before it’s even clear the changes will be necessary. The pandemic has allowed pharma giants to leverage mRNA and other new technologies to dramatically speed up research and development. They’re now faced with having to speed things up yet again to contend with the onslaught of variants.
“We have been preparing for a moment like that for months,” Albert Bourla, chief executive officer of Pfizer Inc., said of the emergence of omicron in an interview with Bloomberg Television. “I feel comfortable that the playbook will work.”
Pfizer started working on a vaccine tailored to stop omicron on Nov. 26, immediately after it was identified. Rival Moderna Inc. mobilized its employees a day earlier—on Thanksgiving Day—to do the same. One reason the two companies can move so quickly is that their mRNA vaccines don’t require growing viruses or proteins in live cells as do traditional vaccine technologies. All that scientists actually need to build an mRNA vaccine is the sequence of a given virus.
この記事は Bloomberg Businessweek の December 06, 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Bloomberg Businessweek の December 06, 2021 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers